These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11792760)

  • 1. Maintenance dialysis population dynamics: current trends and long-term implications.
    Lysaght MJ
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S37-40. PubMed ID: 11792760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
    Port FK
    Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care of undocumented individuals with ESRD: a national survey of US nephrologists.
    Hurley L; Kempe A; Crane LA; Davidson A; Pratte K; Linas S; Dickinson LM; Berl T
    Am J Kidney Dis; 2009 Jun; 53(6):940-9. PubMed ID: 19327878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage renal disease in the United States: an update from the United States Renal Data System.
    Foley RN; Collins AJ
    J Am Soc Nephrol; 2007 Oct; 18(10):2644-8. PubMed ID: 17656472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
    Gilbertson DT; Liu J; Xue JL; Louis TA; Solid CA; Ebben JP; Collins AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3736-41. PubMed ID: 16267160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of end stage renal disease and implications for public policy.
    Rubin RJ
    Public Health Rep; 1984; 99(5):492-8. PubMed ID: 6435162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing body mass index and obesity in the incident ESRD population.
    Kramer HJ; Saranathan A; Luke A; Durazo-Arvizu RA; Guichan C; Hou S; Cooper R
    J Am Soc Nephrol; 2006 May; 17(5):1453-9. PubMed ID: 16597682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dialysis facility of the future: the financial and social environment.
    Steinman TI
    Semin Nephrol; 1997 Jul; 17(4):298-305. PubMed ID: 9241715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care.
    Manns B; Meltzer D; Taub K; Donaldson C
    Health Econ; 2003 Nov; 12(11):949-58. PubMed ID: 14601157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
    Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
    Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.
    Burgess ED; Carides GW; Gerth WC; Marentette MA; Chabot I;
    Can J Cardiol; 2004 May; 20(6):613-8. PubMed ID: 15152291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs of dialysis in the USA.
    Garella S
    Nephrol Dial Transplant; 1997; 12 Suppl 1():10-21. PubMed ID: 9075223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA).
    Zoccali C; Kramer A; Jager K
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S18-22. PubMed ID: 19996000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.